小剂量尿激酶联合低分子肝素治疗进展性脑梗死32例疗效观察
2016-01-29李来喜朱宗亚刘勇程斌汪漩旋
李来喜 朱宗亚 刘勇 程斌 汪漩旋
小剂量尿激酶联合低分子肝素治疗进展性脑梗死32例疗效观察
李来喜 朱宗亚 刘勇 程斌 汪漩旋
【摘要】目的 观察小剂量尿激酶联合低分子肝素治疗进展性脑梗死的疗效与安全性。方法 将62例进展性脑梗死患者随机分为治疗组(32例)与对照组(30例)。对照组采用常规治疗,治疗组在常规治疗基础上,加用尿激酶20万U+生理盐水250 ml静滴,低分子肝素钠5 000 U 皮下注射,每日1次,连用7 d。治疗前、治疗后7 d、14 d对两组患者的神经功能缺损程度评分(NDS)进行评定。 结果 治疗组总有效率90.63%优于对照组70.00%;治疗后NDS 7 d、14 d分别为(12.74±6.72)分、(13.85±7.93)分低于对照组的(24.71±8.51)分、(20.75±9.01)分,P<0.01,差异具有统计学意义;两组均无明显不良反应。结论 小剂量尿激酶联合低分子肝素治疗进展性脑梗死安全有效。
【关键词】尿激酶;低分子肝素;进展性脑梗死
作者单位:242200 安徽广德县人民医院神经内科
Observation Curative Effect of Low Dose Urokinase Combine With Heparin Treatment 32 Cases With Acute Progressive Cerebral Infarction
LI Laixi ZHU Zongya LIU Yong CHENG Bing WANG Xuanxuan Guangde Country People’s Hospital Neurology Department in Anhui Province, Guangde 242200, China
[Abstract]Objective To observe the efficacy and safety of low dose of urokinase combined with low molecular weight heparin in treatment of acute and progressive cerebral infarction. Methods Selected 62 cases with acute cerebral infarction were randomly divided into treatment group (n=32) and the control group (n=30). The treatment group was treated with urokinase 20×104 U and low dose urokinase 5 000 U, the control group was treated routinely therapy. Above-mentioned drug were dissolved in sodium chloride 250 ml iv drip once a day for 7 days respectively. The nervous function defect scores were oberserved before therapy and after treatment at 7 day and 14 day. Results The total effective rate of the treatment group 90.63% was higher than the control group 70.00%, After treatment, the nervous function defect scores at 7 day and 14 day in treatment group were lowed as compared with those in control (12.74±6.72 ) vs (24.71±8.51), P<0.01, had difference statistically significance,(13.85±7.93) vs (20.75±9.01), P<0.01, had difference statistically significance. Conclusion Therapy of use low dose of urokinase combined with heparinin in the acute cerebral infarction is effect and safety.
[Key words]Urokinase, Low molecular weight heparin, Acute progressive cerebral infarction
进展性脑梗死约占缺血性脑血管病20%~40%[1],在经过正规治疗后卒中的原发神经系统症状、体征仍进一步加重,多有病灶扩大、新发及出现并发症等,一般认为在发病后6 h~1周内发生,多数在起病48 h内出现,与不良预后有关,可增加病死率和远期致残率;常规治疗往往疗效欠佳,应用小剂量尿激酶加低分子肝素治疗进展性脑梗死安全、有效,具体报告如下。
1 资料与方法
1.1 一般资料
选择2010年8月~2014年8月我院收治的62例进展性脑梗塞患者,所有患者均为经头颅CT或MRI确诊的发病后48 h内神经功能缺损症状逐渐加重或呈阶梯式加重的缺血性脑卒中患者,排除昏迷、已证实为大面积脑梗死、不符合静脉溶栓及严重心、肺、肝肾功能不全及严重全身系统疾病患者。……
